More News

12 Oct 2021 Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio
11 Oct 2021 Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management
08 Oct 2021 Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
06 Oct 2021 Newly Formed Lanier Biotherapeutics Enters into License Agreement with Alloy Therapeutics
06 Oct 2021 Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
05 Oct 2021 Exo Therapeutics Raises $78 Million Series B Financing
05 Oct 2021 IpiNovyx Bio Closes $10 Million Seed Financing to Advance Best-in-Class Immunoproteasome Inhibitors Toward First-in-Human Clinical Studies
04 Oct 2021 Selecta Biosciences Announces Strategic Licensing Agreement with Takeda to Develop Next-Generation Gene Therapies for Patients with Lysosomal Storage Disorders
01 Oct 2021 Sumitomo Dainippon Pharma and Otsuka Announce a Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds
30 Sep 2021 Merck to Acquire Acceleron Pharma Inc.
30 Sep 2021 Expansion Therapeutics Raises $80 Million Series B Financing to Treat Neurodegenerative Diseases
29 Sep 2021 AstraZeneca to fully acquire Caelum Biosciences
28 Sep 2021 Syndax Pharmaceuticals and Incyte Announce Global Collaboration to Develop and Commercialize Axatilimab for Chronic Graft-Versus-Host Disease and Other Fibrotic Diseases
27 Sep 2021 New startup Aglaia Therapeutics raises €4M in seed funding to overcome resistance in oncology targeted therapies
23 Sep 2021 AstraZeneca to discover and develop self-amplifying RNA therapeutics in new collaboration with VaxEquity
21 Sep 2021 Novartis acquires Arctos Medical, expanding optogenetics portfolio to bring gene therapies to patients with severe vision loss
21 Sep 2021 Boehringer Ingelheim Acquires Abexxa Biologics to Further Expand its Research Efforts in Cancer Immunology and Novel Immunotherapeutic Approaches
21 Sep 2021 858 Therapeutics Launches with Proven Team and $60 Million Series A Financing
21 Sep 2021 Gubra ApS and Bayer AG collaborate to develop next generation cardiorenal treatments
15 Sep 2021 AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines
15 Sep 2021 AzurRx BioPharma Announces Acquisition of First Wave Bio and its Proprietary Niclosamide Formulations Targeting Multi-Billion Dollar Inflammatory Bowel Disease Indications
15 Sep 2021 Nuvectis Pharma In-Licenses Exclusive Worldwide Rights to a Novel SRC/YES1 Inhibitor (NXP900) from the University of Edinburgh, Scotland
14 Sep 2021 Vipergen Establishes Research Partnership with PhoreMost Focused on DNA Encoded Library (DEL)-Based Drug Discovery
14 Sep 2021 AbbVie and REGENXBIO Announce Eye Care Collaboration
11 Sep 2021 Flamingo Therapeutics Expands Alliance with Ionis Pharmaceuticals to Develop RNA-targeted Therapies for Oncology

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top